IP Verse

Modified Antibody, Antibody-Conjugate And Process For The Preparation Thereof - EP2911699

The patent EP2911699 was granted to Synaffix on Sep 10, 2025. The application was originally filed on Oct 23, 2013 under application number EP13786322A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2911699

SYNAFFIX
Application Number
EP13786322A
Filing Date
Oct 23, 2013
Status
Patent Maintained As Amended
Aug 8, 2025
Grant Date
Sep 10, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENOVISAug 14, 2018D YOUNGADMISSIBLE
GENOVISAug 14, 2018KELTIEADMISSIBLE
GLYKOS FINLANDAug 14, 2018PAPULAADMISSIBLE
HGFAug 2, 2018HGFADMISSIBLE

Patent Citations (26) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2005130235
INTERNATIONAL-SEARCH-REPORTWO2005051429
INTERNATIONAL-SEARCH-REPORTWO2005056783
INTERNATIONAL-SEARCH-REPORTWO2007133855
INTERNATIONAL-SEARCH-REPORTWO2008143944
INTERNATIONAL-SEARCH-REPORTWO2009025645
INTERNATIONAL-SEARCH-REPORTWO2009102820
OPPOSITIONUS2005256030
OPPOSITIONUS2007059275
OPPOSITIONUS2009068738
OPPOSITIONUS2011207147
OPPOSITIONUS2012076727
OPPOSITIONUS8008252
OPPOSITIONWO2004063344
OPPOSITIONWO2005051249
OPPOSITIONWO2005051429
OPPOSITIONWO2007095506
OPPOSITIONWO2007133855
OPPOSITIONWO2008029281
OPPOSITIONWO2009025645
OPPOSITIONWO2009067663
OPPOSITIONWO2009102820
OPPOSITIONWO2011136645
OPPOSITIONWO2012121973
OPPOSITIONWO2012134925
OPPOSITIONWO2013037824

Non-Patent Literature (NPL) Citations (48) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- VAN WIJK X M R ET AL, "A 4-deoxy analogue of N-acetyl-d-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro", EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS, US, vol. 316, no. 15, ISSN 0014-4827, (20100910), pages 2504 - 2512, (20100428), XP027166203 [A] 1-60 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- INKA BROCKHAUSEN ET AL, "UDP-Gal: GlcNAc-R [beta]1,4-galactosyltransferase-a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme", GLYCOCONJUGATE JOURNAL, KLUWER ACADEMIC PUBLISHERS, BO, (20061101), vol. 23, no. 7-8, doi:10.1007/S10719-006-7153-X, ISSN 1573-4986, pages 525 - 541, XP019434746 [A] 1-60 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BOEGGEMAN ELIZABETH ET AL, "Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, (20070501), vol. 18, no. 3, doi:10.1021/BC060341N, ISSN 1043-1802, pages 806 - 814, XP002474455 [X] 28,30,37,40,42,43,45,53,56,58,59 * the whole document * [Y] 1-27,29,31-36,38,39,41,46-52,54,55,57 [I] 44,60
INTERNATIONAL-SEARCH-REPORT- ELIZABETH BOEGGEMAN ET AL, "Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycans of Monoclonal Antibodies Using Mutant Glycosyltransferases: Application for Cell Surface Antigen Detection", BIOCONJUGATE CHEMISTRY, (20090617), vol. 20, no. 6, doi:10.1021/bc900103p, ISSN 1043-1802, pages 1228 - 1236, XP055061205 [X] 1-6,10-16,19,20,28-34,37,40-43,45-50,53,56-59 * the whole document * [Y] 22-27 [I] 7-9,17,18,21,35,36,38,39,44,51,52,54,55,60
INTERNATIONAL-SEARCH-REPORT- QASBA PRADMAN K ET AL, "Site-specific linking of biomolecules via glycan residues using glycosyltransferases", BIOTECHNOLOGY PROGRESS,, (20080422), vol. 24, no. 3, doi:10.1021/BP0704034, ISSN 1520-6033, pages 520 - 526, XP009107098 [X] 1-6,10-16,19,20,28-34,37,40-43,45-50,53,56-59 * the whole document * [Y] 22-27 [I] 7-9,17,18,21,35,36,38,39,44,51,52,54,55,60
INTERNATIONAL-SEARCH-REPORT- KHIDEKEL N ET AL, "A CHEMOENZYMATIC APPROACH TOWARD THE RAPID AND SENSITIVE DETECTION OF O-GLCNAC POSTTRANSLATIONAL MODIFICATIONS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ACS PUBLICATIONS, US, (20031231), vol. 125, no. 52, doi:10.1021/JA038545R, ISSN 0002-7863, XP008055588 [A] 1-60 * the whole document *
INTERNATIONAL-SEARCH-REPORT- RAMAKRISHNAN B ET AL, "Structure-based design of beta1,4-galactosyltransferase I (beta4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity. Point mutation broadens beta4Gal-T1 donor specificity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (20020607), vol. 277, no. 23, doi:10.1074/JBC.M111183200, ISSN 0021-9258, pages 20833 - 20839, XP002323111 [A] 1-60 * the whole document *
INTERNATIONAL-SEARCH-REPORT- M. PASEK ET AL, "The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2", GLYCOBIOLOGY, (20120301), vol. 22, no. 3, doi:10.1093/glycob/cwr110, ISSN 0959-6658, pages 379 - 388, XP055061204 [A] 1-60 * the whole document *
INTERNATIONAL-SEARCH-REPORT- QASBA PRADMAN K ET AL, "Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI", AAPS JOURNAL, AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS, US, vol. 8, no. 1, doi:10.1208/AAPSJ080123, ISSN 1550-7416, (20060101), pages E190 - E195, (20060324), XP002491763 [X] 28,30,37,40,42,43,45,53,56,58,59 * the whole document * [Y] 1-27,29,31-36,38,39,41,46-52,54,55,57 [I] 44,60
OPPOSITION- AGGELER et al., "Site-specific click chemistry-mediated labeling of antibody glycans using metabolic and enzymatic approaches", Poster of the 7th Annual PEGS - The Essential Protein Engineering Summit, (20110509), XP055517422-
OPPOSITION- AGGELER et al., "Site-specific labeling of antibody N-glycans using a click chemistry-mediated chemoenzymatic approach", Poster, Annual Meeting of the Association of Biomolecular Resource Facilities (ABRF), (20120317), XP055517428-
OPPOSITION- AGGELER et al., "Site-specific labelling of antibody N-glycans using a click chemistry-mediated chemoenzymatic approach", Poster published at International Symposium of the Association of Biomolecular Resource Facilities, Orlando, FL, USA, (20120317), XP055517428-
OPPOSITION- AGNEW et al., "Site-specific Labeling of Antibody N-glycans using a Click Chemistry-mediated Chemoenzymatic Approach", J. Biomol. Tech., (20120000), vol. 23, page S28, XP055507952-
OPPOSITION- AGNEW et al., "Site-specific labeling of antibody N-glycans using a click March 2012 chemistry-mediated chemoenzymatic approach", Journal of Biomolecular Techniques, (20120000), vol. 23, page S28, XP055507952-
OPPOSITION- "Cycloalkyne", Wikipedia, (20180515), URL: https://en.wikipedia.org/wiki/Cycloalkyne, XP055517474-
OPPOSITION- Flamannet-al .2002 GemtuzumabOzogamicin A Potent and Selective Anti-GD33 OD52Antibody Calicheamicin Conjugate-for the treatment of Acute Myeloid Leukemia. Bioconjugate Chem page 13 47 58-
OPPOSITION- TRIMBLE et al., "Identification of Distinct Endoglycosidase (Endo) Activities in Flavobacterium meningoseptum: Endo F1, Endo F2, and Endo F3", J. Biol. Chem., (19910000), vol. 266, no. 3, pages 1646 - 1651, XP001115067-
OPPOSITION- NING et al., "Visualizing Metabolically Labeled Glycoconjugates of Living Cells by Copper-Free and Fast Huisgen Cycloadditions", Angew. Chem. Int. Ed., (20080000), vol. 47, pages 2253 - 2255, XP002522848
OPPOSITION- LALLANA et al., "Reliable and Efficient Procedures for the Conjugation of Biomolecules through Huisgen Azide-Alkyne Cycloadditions", Angew. Chem. Int. Ed. Engl., (20110000), vol. 50, pages 8794 - 8804, XP055016847
OPPOSITION- DEBETS, MARJOKE F et al., "Azide: A Unique Dipole for Metal-Free Bioorthogonal Ligations", CHEM BIO CHEM, (20100000), vol. 11, no. 9, pages 1168 - 1184, XP055517409
OPPOSITION- RAMAKRISHNAN et al., "Bioconjugation Using Mutant Glycosyltransferases for the Site-Specific Labeling of Biomolecules with Sugars Carrying Chemical Handles", RAMAKRISHNAN et al., Sonny S. Mark, Bioconjugation Protocols: Strategies and Methods, Methods in Molecular Biology, (20110000), pages 281 - 296, XP055517439
OPPOSITION- DOMMERHOLT et al., "Strain-Promoted 1,3-Dipolar Cycloaddition of Cycloalkynes and Organic Azides", To Curr Chem (Z), (20160000), vol. 374, pages 1 - 20, XP055345310
OPPOSITION- TARENTINO et al., "Enzymatic Deglycosylation Of Asparagine-Linked Glycans: Purification, Properties, and Specificity of Oligosaccharide-Cleaving Enzymes from Flavobacterium meningosepticum", Methods in Enzymology, (19940000), vol. 230, pages 44 - 57, XP055311483
OPPOSITION- SHARKEY et al., "Use of antibodies and immunoconjugates for the therapy of more accessible cancers", Adv. Drug Deliv. Rev., (20080000), vol. 60, no. 12, pages 1407 - 1420, XP022851269
OPPOSITION- BARUAH, K. et al., "Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions", J Mol Biol, (20120600), vol. 420, no. 1-2, pages 1 - 7, XP028514772
OPPOSITION- VAN GEEL et al., "Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates", Bioconjug Chem., (20150000), vol. 26, no. 11, pages 2233 - 2242, XP055249394
OPPOSITION- DEBETS et al., "Bioconjugation with Strained Alkenes and Alkynes", Accounts of Chemical Research, (20110000), vol. 44, no. 9, pages 805 - 815, XP002720881
OPPOSITION- BOEGGEMAN ELIZABETH et al., "Direct identification of nonreducing GIcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method", BIOCONJUGATE CHEMISTRY, WASHINGTON, DC, US, (20070501), vol. 18, no. 3, ISSN 1043-1802, pages 806 - 814, XP002474455
OPPOSITION- BOEGGEMAN et al., "Direct Identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method", Bioconjugate Chem., (20070000), vol. 18, no. 3, pages 806 - 814, XP002474455
OPPOSITION- BOEGGEMAN et al., "Direct Identification of Nonreducing GlcNAc residues on N-glycans of Glycoproteins Using a Novel Chemoenzymatic Method", Bioconjugate Chem., (20070000), vol. 18, pages 806 - 814, XP002474455
OPPOSITION- BOEGGEMAN et al., "Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycan of Monoclonal Antibodies Using Mutant Glycosyltransferases Application for Cell Surface Antigen Detection", Bioconjugate Chem., (20090000), vol. 20, pages 1228 - 1236, XP055061205
OPPOSITION- BOEGGEMAN et al., "Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycans of Monoclonal Antibodies Using Mutant Glycosyltransferases: Application for Cell Surface Antigen Detection", Bioconjugate Chem., (20090000), vol. 20, no. 6, pages 1228 - 1236, XP055061205
OPPOSITION- ELIZABETH BOEGGEMAN et al., "Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycans of Monoclonal Antibodies Using Mutant Glycosyltransferases: Application for Cell Surface Antigen Detection", BIOCONJUGATE CHEMISTRY, (20090617), vol. 20, no. 6, ISSN 1043-1802, pages 1228 - 1236, XP055061205
OPPOSITION- QASBA et al., "Site-specific linking of biomolecules via glycan residues using glycosyltransferases", Biotechnology Progress, (20080422), vol. 24, no. 3, pages 520 - 526, XP009107098
OPPOSITION- QASBA PRADMAN K et al., "Site-specific linking of biomolecules via glycan residues using glycosyltransferases", BIOTECHNOLOGY PROGRESS, (20080422), vol. 24, ISSN 1520-6033, pages 520 - 526, XP009107098
OPPOSITION- AGARD et al., "A Strain-Promoted [3 + 2] Azide-Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems", J. Am. Chem. Soc, (20040000), vol. 126, pages 15046 - 15047, XP002362785
OPPOSITION- GOODFELLOW et al., "An Endoglycosidase with Alternative Glycan Specificity Allows Broadened Glycoprotein Remodelling", J. Am. Chem. Soc., (20120000), vol. 134, pages 8080 - 8033, XP055101799
OPPOSITION- GOODFELLOW, J.J. et al., "An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling", Journal of the American Chemical Society, (20120500), vol. 134, no. 19, pages 8030 - 8033, XP055101799
OPPOSITION- HUANG et al., "Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions", J. Am. Chem. Soc., (20120000), vol. 134, pages 12308 - 12318, XP055035929
OPPOSITION- DEBETS et al., "Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3+2) cycloaddition", Chem. Commun, (20091106), vol. 46, pages 97 - 99, XP002599643
OPPOSITION- RAMAKRISHNAN et al., "Structure-based Design of beta1,4- Galactosyltransferase I (beta4Gal-T1) with Equally Efficient N- Acetylgalactosaminyltransferase Activity", J. Biol. Chem., (20020607), vol. 277, no. 23, pages 20833 - 20839, XP002323111
OPPOSITION- COLLIN, M et al., "Endo S, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG", The EMBO Journal, (20010000), vol. 20, no. 12, pages 3046 - 3055, XP002486737
OPPOSITION- COLLIN, M et al., "Extracellular Enzymes with Immunomodulating Activities: Variations on a Theme in Streptococcus pyogenes", Infection and Immunity, (20030600), vol. 71, no. 6, pages 2983 - 2992, XP002426769
OPPOSITION- JUNUTULA, J et al., "Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer", Clin Cancer Res, (20100000), vol. 16, no. 19, pages 4769 - 4778, XP002727053
OPPOSITION- QASBA et al., "Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI", AAPS Journal, (20060000), vol. 8, no. 1, pages E190 - E195, XP002491763
OPPOSITION- QASBA PRADMAN K et al., "Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI", THE AAPS JOURNAL, (20060000), vol. 8, no. 1, pages E190 - E195, XP002491763
OPPOSITION- ALLHORN M et al., "Human IgG/FcyR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis", PLoS ONE, (20080100), vol. 3, no. 1, pages 1 - 12, XP002486739
OPPOSITION- LUGOVSKOY et al., "7th Annual European Antibody Congress 2011", mAbs, (20120000), vol. 4, no. 2, pages 134 - 152, XP002678622

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents